Clinical Trials in Germany — Country Dashboard | 3,914 EU Studies

Filter these 3,914 trials by condition, phase, sponsor and more.

Open in Search →

3,914 Registered trials

1,466 Recruiting

2,135 Completed trials

967 Sponsors active

2,428 Research sites

Phase III

Phase II

Phase III: 1702 Phase II/III: 163 Phase II: 1033 Phase I/II: 215 Phase III/IV: 28 Phase IV: 137 Phase I: 197 Phase I (Other): 297 Phase I (FiH): 120 Other: 21 Other: 1

Oversight events in trials active here:

118 serious breaches 844 temporary halts 65 urgent safety measures 91 unexpected events 153 corrective measures across 498 trials

View oversight register →

Top conditions

Non-small cell lung cancer 112 Systemic lupus erythematosus 38 Non-small cell lung cancer metastatic 38 Breast cancer 28 Ovarian cancer 28 Colorectal cancer 28 Rheumatoid arthritis 27 Asthma 26 Obesity 25 Crohn's disease 24 Pulmonary arterial hypertension 23 Colitis ulcerative 23

Top sponsors

AstraZeneca AB 166 Novartis Pharma AG 166 Merck Sharp & Dohme LLC 145 Boehringer Ingelheim International GmbH 126 F. Hoffmann-La Roche AG 124 Janssen - Cilag International 113 AbbVie Deutschland GmbH & Co. KG 89 Sanofi-Aventis Recherche & Developpement 80 Novo Nordisk A/S 67 Pfizer Inc. 67 Amgen Inc. 58 Eli Lilly & Co. 58

Cities with most trials

All 569 cities →

All trials — page 33

3,914 total

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination with Atezolizumab… Recruiting

2024-517490-24-00 Phase II Small Cell Lung Cancer AbbVie Deutschland GmbH & Co. KG
A clinical trial to learn about the effects of AMO959 given with AAA617 and an androgen receptor pathway inhibitor (ARPI) in adults with PSM… Recruiting

2025-521859-23-00 Phase I/II PSMA-positive mCRPC with prior exposure to at least one prio… Novartis Pharma AG
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 Recruiting

2025-521973-16-00 Phase I/II Netherton Syndrome Biocryst Pharmaceuticals Inc.
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study Recruiting

2025-522338-30-00 Phase II Ulcerative Colitis Eli Lilly & Co.
Local Tenecteplase ApplicatiOn subsequent to endovasCular Recanalization in Anterior CircuLation Stroke - the LOCAL trial Recruiting

2024-516544-26-00 Phase II acute ischemic stroke Universitaetsklinikum Heidelberg AöR
A study to learn if galvokimig is safe and works in adults with moderate to severe atopic dermatitis Recruiting

2025-522578-35-00 Phase II Atopic Dermatitis UCB Biopharma
Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Previously Untreated, Unresectable, or Met… Recruiting

2025-523224-45-00 Phase II/III Untreated, Unresectable or Metastatic Colorectal Cancer Bristol-Myers Squibb Services Unlimited Company
A first study in humans testing the safety and effects of KUP-101A in patients with certain advanced solid cancers Recruiting

2025-522402-21-00 Phase I Advanced solid tumors (cutaneous melanoma, mucosal melanoma,… Kupando GmbH
TRITON-PN: A Phase 3 Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Hereditary Transthyretin Amyloidosis with Poly… Recruiting

2025-522544-40-00 Phase III Hereditary transthyretin-mediated amyloidosis with polyneuro… Alnylam Pharmaceuticals Inc.
Visugromab in Cachexia International Trial Recruiting

2025-523533-25-00 Phase II/III Cancer-associated Cachexia CatalYm GmbH
Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes Recruiting

2025-521595-55-00 Phase I (Other) Type 2 Diabetes Novo Nordisk A/S
A clinical study of opevesostat and standard hormone therapy in people with prostate cancer (MK-5684-004) Recruiting

2023-504957-11-00 Phase III Metastatic castration resistant prostate cancer Merck Sharp & Dohme LLC
Not Applicable Recruiting

2024-511198-31-00 Phase II/III Lupus Nephritis Kyverna Therapeutics Inc.
A study to learn about how safe BAY 3389934 is, its suitable dose, and how it affects the participants with sepsis and coagulopathy Recruiting

2024-515635-30-00 Phase I (Other) Coagulopathy Bayer AG
A study to test how well PLENVU®, a bowel cleansing medicine, works in children and teenagers before they have a colonoscopy exam Recruiting

2025-522046-42-00 Phase III Colonic disease Norgine Limited
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) Recruiting

2025-522674-36-00 Phase III Metabolic Dysfunction-Associated Steatotic Liver Disease Eli Lilly & Co.
An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease Recruiting

2025-521036-11-00 Phase III Immune system disseases Sanofi-Aventis Recherche & Developpement
A study to test whether nerandomilast can help slow down changes in the lung in people with a family history of pulmonary fibrosis Recruiting

2025-522383-33-00 Phase III Pulmonary fibrosis Boehringer Ingelheim International GmbH
A study to learn about the effectiveness and safety of different doses of JNJ-88545223 in people with active psoriatic arthritis Recruiting

2025-523141-10-00 Phase II Active Psoriatic Arthritis Janssen Cilag International
A research study looking at how NNC0487-0111 affects food intake, appetite and metabolism after meals in people with obesity Recruiting

2025-521393-34-00 Phase I (Other) Participants with obesity, but otherwise healthy Novo Nordisk A/S
Phase 3 study of VGA039 prophylaxis in adolescent and adult patients with von Willebrand Disease Recruiting

2025-522056-10-01 Phase III von Willebrand Disease Vega Therapeutics Inc.
Phase III Study of Rilvegostomig in Combination withBevacizumab with or without Tremelimumab as First-lineTreatment of Hepatocellular Carcin… Recruiting

2024-518210-81-00 Phase III Advanced Hepatocellular Carcinoma AstraZeneca AB
A Study to Learn About the Study Medicine Called Ritlecitinib in People With Hives Without a Known Cause Recruiting

2025-522642-44-00 Phase II CHRONIC SPONTANEOUS URTICARIA Pfizer Inc.
A clinical trial to test if an investigational combination therapy with BNT326 and BNT327 is safe and potentially beneficial for people with… Recruiting

2024-519344-32-00 Phase I/II Non-small Cell Lung Cancer BioNTech SE

Showing 769–792 of 3,914 trials

← All countries